HAWKHILL THERAPEUTICS Ltd

Amendment
CIK: 0002140690·Biotechnology·UNITED KINGDOM·Filed: Sep 28, 2026
Total Offering

$290,530

Amount Sold

$290,530

Investors

1

First Sale

Apr 7, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
Christopher Andrew Woodland
Related Person
Antoine Boulanger
Related Person
Mary Canning
Related Person
Francisca Peixoto
Related Person
Timothy Jason Sparey
Related Person

Company

HAWKHILL THERAPEUTICS Ltd

LIFE SCIENCES INNOVATION HUB

DUNDEE, SCOTLAND, X0, DD1 5JJ

5555555555

SEC Filing

0002140690-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free